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Abstract
The ability of three sterols of different structure to influence the interaction of syringomycin E an antifungal antibiotic
.that forms voltage dependent channels in planar lipid bilayers with a planar lipid bilayer was evaluated. The rate of
increase of bilayer conductance induced by syringomycin E was about 1000-times less in bilayers containing 50 mol% of
 .cholesterol compared to bilayers without sterols. The effect of ergosterol the primary sterol of fungal cells on the
sensitivity of bilayers to syringomycin E was much weaker than that of cholesterol, while stigmasterol one of the main
.sterols of plant cells did not significantly influence the ability of syringomycin E to induce a conductance increase in the
bilayer. None of the sterols altered the single channel conductance properties of syringomycin E. These observations
suggest that cholesterol affects the sensitivity of target membranes to syringomycin E by enlarging the energy barrier for
channel formation rather than participating in channel formation itself.
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1. Introduction
Syringomycin E and its analogues are antifungal
cyclic lipodepsipeptides produced by certain strains
of the bacterium Pseudomonas syringae pv. syringae
w x1,2 . Physiological and biochemical studies have
 .shown that syringomycin E Fig. 1 acts on the fungal
plasma membrane altering several of its functions,
including Hq, Ca2q, and Kq transport, protein phos-
q w xphorylation, and H -ATPase activity 1–4 . It was
)  .Corresponding author. Fax: q1 215 8982084; e-mail: fei-
gin@pobox.upenn.edu.
reported that syringotoxin, a related cyclic lipodep-
sipeptide, forms anion selective, voltage-sensitive
w xchannels in planar lipid bilayers 5,6 . Hutchison et
w xal. 7 reported that syringomycin E induced single
channel activity in planar lipid bilayers. We further
w xobserved 8 that syringomycin E induces channels
w xthat, similar to those of colicin E1 9 , are opened by
positive voltages and closed by negative voltages.
Experiments with yeast cells demonstrate that,
similar to the polyene class of antifungal drugs, the
antifungal activity of syringomycin E is dependent
upon the presence of certain sterols in the plasma
w xmembrane of the fungal cells 10,11 . Syringomycin
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E-resistant mutants of Saccharomyces cere˝isiae
were analyzed to determine the number and functions
of genes necessary for growth inhibition by syringo-
w xmycin E 10 . Among eight genetic classes of mu-
tants, five were also resistant to the polyene antibi-
otic, nystatin. Since nystatin binds to ergosterol a
sterol found specifically in fungal plasma mem-
.branes , it was speculated that the mutants had alter-
ations in ergosterol levels. Further analysis showed
that the mutants were indeed deficient in ergosterol in
w xcomparison with the parent strain 10,12 , suggesting
that sterols are required for syringomycin E action.
 .The possible role s of sterols in the interaction of
syringomycin with the target membranes remained
unclear.
While studying the mechanism of membrane activ-
ity of syringomycin with the planar lipid bilayer
technique, we observed that the antibiotic forms ion
w xchannels in bilayers containing no sterols 8 , al-
though a possible role for sterols as modulators of
membrane sensitivity to syringomycin remained un-
studied. Here we present the results of our studies on
the influence of sterols of different structure on the
sensitivity of planar bilayers to syringomycin E as
well as on the properties of single channels induced
by syringomycin E.
2. Materials and methods
Synthetic 1,2-dioleoyl-sn-glycero-3-phosphoserine
 .DOPS and 1,2-dioleoyl-sn-glycero-3-phosphatidyl-
 .  w x.Fig. 1. Structures of syringomycin E zwitterionic form from Fukuchi et al. 41 and the sterols, cholesterol, ergosterol, and stigmasterol
employed in this report. Abbreviations: Arg, arginine; OH-Asp, 3-hydroxyaspartic acid; Dab, 2,4-diaminobutyric acid; Dhb, dehydro-2-
aminobutyric acid; Cl-Thr, 4-chlorothreonine; Ser, serine; Phe, phenylalanine.
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 .ethanolamine DOPE were purchased from Avanti
Polar Lipids, Pelham, AL. The sterols, cholesterol,
ergosterol and stigmasterol, were purchased from
Sigma Chemical Co., St. Louis, MO. All electrolytes
were reagent grade. Water was doubly distilled and
deionized. Salt solutions for bilayer experiments were
100 mM NaCl buffered by 5 mM MOPS to pH 6.0.
Syringomycin E was purified to homogeneity as de-
w xscribed previously 13 .
Virtually solvent-free bilayers were prepared as
w xdescribed by Montal and Mueller 14 . Two symmet-
rical halves of a Teflon chamber with solution vol-
umes of 1 cm3 were divided by a 15-mm-thick
Teflon partition containing a round aperture of about
30 mm diameter. Hexadecane in n-hexane 1:10,
.vrv was used for aperture pretreatment. ‘Virtual
ground’ was maintained at the trans side of the
bilayer. Hence positive voltages mean that the cis
side compartment is positive with respect to the trans
side. Positive currents are therefore those of cations
flowing from cis to trans. All experiments were
performed at room temperature. A detailed descrip-
tion of methods used for bilayer preparation and
single channel data analysis may be found elsewhere
w x15,16 .
Syringomycin E was added to the aqueous phase at
 . one cis side of the bilayer from stock solutions 1
.mgrml in water.
2.1. Sensiti˝ity of bilayers of ˝arying sterol composi-
tion to syringomycin E
The common approach to estimating the sensitivity
of membranes to channel-forming agents is to mea-
sure the dependence of bilayer steady-state conduc-
tance on the concentration of the channel-former in
the bath solution. However, with syringomycin, mea-
suring the dependence of bilayer steady state conduc-
w xtance on the concentration 8 with a constant voltage
across the bilayer was very difficult, because a steady
state can be reached only across a narrow range of
low voltages. It was necessary, therefore, to choose
an alternative approach to measuring the sensitivity
of bilayers to syringomycin. This alternative tech-
nique makes use of the dependence of turn-on rate of
the conductance increase instead of steady-state con-
.ductance on the applied positive voltage at a con-
 .stant concentration of syringomycin E 3 mgrml in
the cis compartment of the bath solution.
2.2. Voltage dependence of turn-on rates
The turn-on and turn-off macroscopic current ki-
netics following the application of positive and nega-
tive voltage pulses, respectively, to the bilayers doped
with one side addition of channel-former are very
w x w xsimilar for syringomycin E 8 and for colicin E1 9 .
w xBased on the logic developed by Abrams et al. 9 ,
we used the voltage dependence of turn-on rates to
compare the effect of a given concentration of sy-
ringomycin E in bilayers containing sterols of vary-
ing structure. We assume that gating of the syringo-
mycin E channel is a two-state process switching




and all channels are initially in the closed state, i.e.,
w xo s0. Then initiallyts0
d o rd tsk c1
or
d grd ts g d o rd ts g k c .  .single channel single channel 1
where g is the syringomycin-induced conductance.
Therefore, if the total number of channels open plus
.closed in the membrane remains constant, and all of
the channels are initially closed, d grd t will be linear
and proportional to k at short times after turn-on1
pulses are applied. In experiments designed to mea-
sure the voltage dependence of d grd t, positive volt-
age pulses of sufficient amplitude were applied to
insure that subsequent linear increases in conductance
for short times represented only a small fraction of
the total possible bilayer conductance. Voltage was
alternated between positive and subsequent negative
pulses from 40 mV to 200 mV in steps of 20 mV. For
example, first q40 mV is applied. If there is no
effect, the voltage is turned off, and then q60 mV is
applied. If, now, the current grows, after 10–60 s, the
voltage is switched to y60 mV. After the conduc-
tance comes to zero, q80 mV is applied, and so on.
Prior to each successive positive pulse, the negative
one was applied to bring the conductance to zero.
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Initial turn-on rates were determined from the slope
w .d Ird t of the I vs. t line at short times at thets0
beginning of the growth of the current, after this
 .  .process became linear see Fig. 2C . d Ird t wasts0
 .converted to d grd t and plotted semi-logarith-ts0
 .mically as a function of voltage. The ln d grd t ts0
vs. V was linear, and its slope was fitted using a
non-linear least-squares fitting program Origin 4.0,
.Microcal Software, MA, USA .
For each applied voltage the average value of
 .d Ird t was estimated using 3–5 membranes.ts0
3. Results
3.1. The macroscopic conductance of bilayers modi-
fied with syringomycin E
We demonstrated earlier that the addition of sy-
ringomycin E to the bath solution at one side of a
bilayer induced an increase in bilayer conductance in
w xa voltage-dependent manner 8 . The formation of
channels in bilayers made from DOPS doped with
 .syringomycin E at one side 1–40 mgrml was
Fig. 2. Time course of the bilayer current in field-reversal experiments in the presence of syringomycin E with the bilayers of different
 .  .  .  .  .sterol composition – A DOPErDOPSs1:1 no sterols ; B DOPErDOPSrergosterols1:1:2 mole ; C DOPErDOPSrstigmasterol
 .  .s1:1:2; and D DOPErDOPSrcholesterols1:1:2. The application of positive voltage marked by the solid arrows was followed by a
 . step-like change to negative voltage of the same amplitude marked by the dotted arrows . The concentration of syringomycin E cis side
.   ..only in the bathing solution 100 mM NaCl, 5 mM MOPS pH 6.0 was 3 mgrml. Syringomycin E was added to bath 10–20 min
before the records were taken. An example of fitting of the slope of the linear part of the beginning of the current growth after the
application of positive voltage is shown in panel B. The dotted line is the theoretical curve.
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greatly affected by cis-positive voltage. A change of
voltage from a positive to a negative value resulted in
 .1 an abrupt increase in the single channel conduc-
 .tance the rate of increase was voltage-dependent ,
 .simultaneous with 2 a closing of these channels and
an exponential decrease in macroscopic conductance
w xover time 8 .
Examples of the time course of current across a
bilayer formed from the equimolar mixture of DOPS
 .and DOPE with different sterols 50 mol% modified
by one-sided addition of syringomycin E in response
to, first, a positive voltage step, and then, a negative
one are shown in Fig. 2. It is clear from the data
depicted in Fig. 2 that addition of any of the three
sterols to the bilayer-forming lipid solution does not
qualitatively change the effect of field sign: in all
cases we observed an increase in the bilayer conduc-
tance at positive voltages and the decrease in this
conductance at negative voltages. This observation
suggests that the presence of sterols does not change
the conformation of the syringomycin channels, and
Fig. 3. The curves of dependence of the rate of conductance
 .increase d grd t on the applied positive voltage for bilayers of
different sterol composition DOPErDOPSs1:1 with or without
.50 mol% of either ergosterol, stigmasterol, cholesterol are calcu-
lated from data similar to those presented in Fig. 2. All rates of
current increase were measured at different applied voltages at
the same concentration of syringomycin – 3 mgrml in the bath
solution at the cis side only. Experimental points are averages
from 3–5 bilayers. The error bars represent standard deviations.
The calculated slopes of the curves are 17"1.4, 14.9"1.4,
15.9"1.2, and 15.3"1.6 for bilayers containing no sterols,
stigmasterol, ergosterol, and cholesterol, respectively.
Fig. 4. Records of transmembrane current of bilayers containing a
 .few syringomycin E channels at negative potentials cis side
o b ta in e d w ith c h o le s te ro l c o n ta in in g b ila y e rs
 .DOPErDOPSrcholesterols1:1:2; B, D and bilayers without
 .  .sterols DOPErDOPSs1:1; A, C , at y120 mV A, B and
 . y180 mV C, D . The concentration of syringomycin E cis side
.  only in the bathing solution 100 mM NaCl, 5 mM MOPS pH
..6.0 was 3 mgrml. Channel closings and openings are repre-
sented by upward and downward deflections, respectively. Data
were filtered at 30 Hz, digitized at 1 kHz.
thus, does not alter their response to an applied
voltage.
However, the presence of cholesterol greatly de-
creases the sensitivity of bilayers to syringomycin E.
Functions describing the dependence of the rate of
 .conductance increase d grd t to the applied positive
voltage for bilayers of different composition the
same concentration of syringomycin E in all cases, 3
.mgrml at cis side only are shown in Fig. 3. These
curves were calculated from studies of current kinet-
ics, similar to those presented in Fig. 2. It is clear
from the data shown in Fig. 3 that syringomycin E is
much less effective at inducing conductance increases
in bilayers containing 50 mol% of cholesterol com-
pared with those cases of bilayers containing 50
mol% of ergosterol, or stigmasterol, or in bilayers
containing no sterols. The values of the shift of the
curves of d grd t versus voltage relative to the bilay-
.ers without sterols are q117 mV, q39 mV and 0.4
mV for cholesterol-, ergosterol-, and stigmasterol-
containing bilayers, respectively. The addition of
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sterols had a minor effect on the slopes, averaging an
e-fold increase in the value of d grd t for every 16
mV. The observed voltage shifts corresponded to
1150- and 10-fold differences in the values of d grd t
at any given voltage for cholesterol- and ergosterol-
containing bilayers, respectively, compared with the
bilayers without any sterols or bilayers with stigma-
sterol.
 .The data demonstrate that 1 the addition of sterols
to the bilayer does not change the slope of the
dependence of rate of increase of membrane conduc-
 .tance on applied positive voltage; 2 cholesterol
strongly diminishes the effect of syringomycin, while
the effect of ergosterol on the sensitivity of bilayer to
syringomycin is much weaker than that of chole-
sterol, and stigmasterol is ineffective.
3.2. The properties of single channels formed by
syringomycin E in planar lipid bilayers of different
sterol composition
Examples of single channel activity observed in
planar lipid bilayers formed from the mixture
DOPErDOPS s 1:1 without sterols or from
 .DOPErDOPSrcholesterols1:1:2 mole at y120
mV and y180 mV are presented in Fig. 4. There is
no difference in the unitary conductance of channels
in bilayers of different composition including bilay-
Fig. 5. Voltage dependence of single channel conductances ob-
tained from the records of single channel activity induced by
 .syringomycin E cis side only, 3 mgrml in the bathing solution
  ..100 mM NaCl, 5 mM MOPS pH 6.0 with cholesterol contain-
 .ing bilayers DOPErDOPSrcholesterols1:1:2 and bilayers
 .without sterols DOPErDOPSs1:1 .
ers containing ergosterol or stigmasterol data not
..shown . This is true for the range of voltages be-
 .tween y100 to y200 mV Fig. 5 . In all cases the
conductance grows from 26 pS at y100 mV to 60 pS
at y200 mV the conductance values refer to the
.main conductive state , demonstrating that the pres-
ence of the 50 mol% of the sterol either cholesterol,
.ergosterol, or stigmasterol does not alter either the
channel conductance or its dependence on the applied
voltage.
4. Discussion
4.1. The role of sterols in syringomycin acti˝ity
The sterols of plasma membranes of eucaryotic
cells often play important roles in determining the
sensitivities of these membranes to antibiotics and
toxins whose activity depends upon increasing mem-
brane permeability. For example, sterols are essential
for the cytolytic activity of several large bacterial
polypeptide toxins, such as pneumolysin and strep-
w xtolysin-O 17 . Inclusion of cholesterol in the target
w xmembranes strongly potentiates a-toxin effects 18 .
The glycoalkaloids a-solanine, a-chaconine and a-
w x.tomatine 19 and the lipopeptide antibiotic iturin A
w x20 interact with sterol-containing bilayers, increas-
ing membrane permeability. Sterols are important
parts of the actual channels formed by polyene antibi-
w xotics 17,21,22 , although membranes in the gel state
 .not common in cells , even without sterols, may be
w xmade permeable by polyene antibiotics 23,24 . Yeast
mutants resistant to polyene antibiotics usually have
lesions in ergosterol biosynthesis, and these mutants
w xaccumulate sterols other than ergosterol 25,26 .
Recent experiments with yeast cells demonstrate
that, similar to the polyene class of antifungal drugs,
the antifungal activity of syringomycin E is depen-
dent upon the presence of certain sterols in the
w xplasma membrane of the fungal cells 10,11 .
The role of membrane sterols in the interaction of
syringomycin E with membranes can be hypothesized
to be one of the following.
1. There is a direct interaction with syringomycin E
in the formation of the pore structure, i.e., sterols
are components of the channel complex.
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2. Sterols provide conditions conducive to the assem-
bly and disassembly of channels, but they are not
components of channel structure.
To clarify which of these two hypotheses is true,
we performed experiments similar to those used pre-
viously to clarify the role of lipid components in the
formation of channels induced by other agents, in-
cluding polyene antibiotics, alamethicin and magainin
 .2 see below . If sterols directly participate in the
formation of syringomycin E-induced channels, it can
be expected that their presence and structure will
influence the internal structure of channels. There-
fore, channel conductance as well as sensitivity of the
bilayers to the channel-former will be affected. Such
effects have been reported in the ability of sterol
structure to influence the conductance of amphoteri-
w xcin B-induced channels 27 , the conductance of
channels formed by the water-soluble mitochondrial
w xporins 28 , the influence of phospholipid structure on
the ion selectivity of channels induced by the
w xpolypeptide antibiotic, magainin 2 29 , and on sensi-
w xtivity of lipid bilayers to magainin 2 30 .
If sterols influence membrane sensitivity without
directly participating in the formation of syringo-
mycin E channels, it is expected that this influence
may result from the effect of sterols on the surround-
ing environment of the syringomycin E channels and
thus, on the partitioning of syringomycin E between
the membrane interior and its surface or electrolyte
.solution . This effect would likely occur without a
change in the channel properties. Such an influence
on membrane sensitivity was observed for cholesterol
on the voltage-dependent conductance induced by
w xalamethicin 31,32 .
The results of the present study suggest that the
second hypothesis may more readily explain the ef-
fect of cholesterol on the interaction of syringomycin
E with lipid bilayers. We demonstrated that choles-
terol-containing bilayers are much less sensitive to
syringomycin E than are bilayers containing ergo-
 .sterol, stigmasterol or no sterols at all Fig. 3 . We
observed no difference in single channel conductivity
or in responses of bilayer current to a change of
polarity of transmembrane potential among the bilay-
 .ers of different sterol composition Fig. 2 and Fig. 5 .
Also, the slope of the function, d grd t versus voltage
 .Fig. 3 , does not change with the modification of the
sterol composition of bilayers. This slope is directly
related to the value of the effective gating charge,
which is equal to the product of the value of electric
charge responsible for the channel voltage gating and
the distance that this charge passes after the voltage
w xis applied 33 . The unchanged slope, therefore, im-
plies a lack of effect on channel conformation. Taken
 .together, our data suggest that: i sterols do not
change the properties of the syringomycin E channels
in the bilayer and thus, they do not participate di-
 .rectly in syringomycin E channel formation; ii the
presence of cholesterol in the bilayer increases the
energy barrier for the syringomycin channel forma-
tion. Therefore, in cholesterol-containing bilayers,
higher voltages are necessary to induce a given level
of membrane conductance.
4.2. Why does cholesterol protect membranes better
than ergosterol and stigmasterol?
The presence of ergosterol influenced bilayer sen-
sitivity to a much lesser extent compared with chole-
 .sterol, while stigmasterol was inactive Fig. 3 . These
results are consistent with previous observations of
protection by exogenously added cholesterol against
w xsyringomycin E inhibition of yeast growth 34 . Inter-
estingly, protection was afforded only at times soon
after syringomycin E addition and not at later times,
suggesting that cholesterol interferes with the initial
processes leading to cytotoxicity. Furthermore, ergo-
sterol and stigmasterol afforded some, but signifi-
cantly less, protection against cytotoxicity.
The question as to why cholesterol is the most
active sterol in protecting bilayers against syringo-
mycin E should be addressed. In general, the ability
of sterols to influence membrane sensitivity to a drug
depends on the structural features of the sterol
molecule. These features are more-or-less specific for
each drug. For example, the ability of sterols to
increase the sensitivity of planar lipid bilayers to
amphotericin B correlated with the presence of the
w x5,7-diene system in the sterol molecule 35–37 . The
presence of a double bond or a methyl group in the
side chain of the sterol molecule was without effect.
The presence of the 5,7-diene system completely
blocked the ability of sterols to inactivate gramicidin
w xA channels in planar lipid bilayers 38 . In contrast,
the sensitivity of membranes to iturin A and glycoal-
kaloids was strongly dependent on the structure of
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the sterol side chain, but not on the presence of the
w x5,7-diene system in the sterol nucleus 19,39 . A
theoretical analysis revealed a qualitative difference
between cholesterol and ergosterol in the distribution
of molecular electrostatic potential around the side
w xchain 40 .
Our results suggest that branching of the side chain
of sterol molecules andror the presence of the double
bond at C –C decreases the ability of sterols to22 23
protect the membrane against syringomycin E activ-
ity. The occurrence of these structural features is the
main difference between stigmasterol with an ethyl
.group at C and a double bond at C –C and24 22 23
ergosterol with a methyl group at C and a double24
.bond at C –C on the one hand, and cholesterol22 23
with no alkyl substituents at C , and no double24
. bond at C –C on the other. The structures of22 23
.these three sterols are presented in Fig. 1. The
importance of the side chain structure of the sterol is
further supported by the fact that the remaining moi-
 .eties of stigmasterol with no protective activity and
 .cholesterol with high protective activity are identi-
cal.
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